aMBR Genomics
Madison, US · Founded 2025 · Delaware corporation
Find your way into aMBR Genomics
Sign up to see every warm intro you have to aMBR Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the aMBR Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MM

Michael MoserVP of Research and DevelopmentHe has over a decade of experience as a principal investigator developing FDA-regulated products, with 30 publications, 13 patents, and $4.7M in secured funding.
AS
Ahna SkopNamed on SEC filing
EY
Eugene YeoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2025
▶$1.1MraisedMar 2026 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedMar 2026 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ahna SkopExecutive Officer, Director
- Michael MoserExecutive Officer
- Eugene YeoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.1M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has aMBR Genomics raised?
- aMBR Genomics has disclosed $1.1M raised across 1 round.
- Where is aMBR Genomics headquartered?
- aMBR Genomics is headquartered in Madison, US.